green sap®
Tropfen gegen Krebs
Es ist ein 100%iges pflanzliches Naturprodukt

 
GREEN SAP IN IHREM LAND
 

Letzte Änderung::

     
HAUPSEITE ·
Dr. Bernardo Udaquiola ·
Wissenschaftliche ·
Forschung ·
Ursprung des Produktes ·
Aktionsmechanismus ·
Veterinärmedizin ·
Einige Fälle ·
Häufig gestellte Fragen ·
Dosierung ·
ON LINE BERATUNG ·
GREEN SAP ERHALTEN ·
Möchten Sie uns ·
vertrenten? ·
Interessante Links ·
Labeco NEWS ·


Contact us:
info@greensap.com

Hersteller:

Lab. Ameripharma S.A.

Av. Refinería #3 Zona

Industrial de Haina.

Santo Domingo,

Rep. Dominicana

Unter Lizenz von:

Pho. (+598) 2 307.1944
Fax. (+598) 2 308.7051

LABECO LTDA.
www.labeco.com.uy
Valentín Gómez 1045
Montevideo - Uruguay

Lung cancer cases

Case 1: Lung Cancer with Brain Metastasis

Name: Liliana Calzada
Age: 48 years old
Country: Argentina
Reason of consultation:
07/20/2002 We are sent Clinic Registers to evaluate the clinic case and begin the treatment.
Personal antecedents:
Without personal antecedents to remark.
Family antecedents:
None to remark.
Present disease antecedents:
Antecedent of right lung-ectomy due to esquamous carcinoma (01/24/2000) with adjuvant treatment (chemotherapy and radiotherapy), with good afterwards evolution. Then she begins with symptomatology suggestive of encephalic compromise reason why total macroscopic exams are performed on 04/20/2001. Presenting left back parietal encephalic mass. Neurological evolution was favorable in the post-surgery, presenting as an intercurrence surgery scar reason why the bone plaque was removed. In the MNR control presented local recidivism that underwent surgery in the left parietal sector where had been the first time. It was found dural infiltration by neoplasic cells. The dural fraction and the tumor recidivism were extirpated totally performing duramadre’s plastia. Good post-surgery evolution. She was derived again to oncology. The patient has received chemotherapy in 2 lines first CCCP plus VP 16 andn then carboplatine-vinorelbine, also RDT and chemotherapy in thorax and central nervous system. Because of this data we indicate 60 drops orally or sublingually every 6 hours.
Disease evolution:
09/06/2002: Great improvement of his neurological symptomatology with large reduction of pathological image in the central nervous system. She goes on stable without progress of her disease until the present moment. She goes on with 60 drops sublingually every 6 hours.
10/15/2002: Telephone communication with the patient where she informs us she presented convulsions. She had a CAT done which showed disappearance of the metastasis.
11/11/2002: We had a telephone conversation with the patient where she informed us she goes on stable. We suggested her anti-convulsive treatment.
02/15/2003: By telephone communication it is indicated to maintain the treatment as at the moment.
Conclusions:
With no doubt GREEN SAP has benefited the patient who has a grave and of difficult treatment disease, avoiding convulsions (which she had) and achieving a remarkable improvement either in the primitive tumor as in the metastasis. GREEN SAP has a marked anti-neoplasic action in which the GREEN SAP medical staff has a practice of years. The medicament has been of remarkable efficacy in this patient, who leads a normal life.

  ----------------